T2L-15566-25031
3 vaccinations
3 coded responses
37 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 940 / CA
- Registered
- 2021-06-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
3SV-15219-70590
Child or adolescent in my care · Female · 2022-06-25
Timeline
-
2021-06-01
Registered in v-safe
-
2021-06-01
Dose 1 — Pfizer-BioNTech
- 2021-06-01
- 2021-06-02
- 2021-06-03
- 2021-06-04
- 2021-06-05
- 2021-06-06
- 2021-06-07
- 2021-06-08
- 2021-06-15
-
2021-06-22
Dose 2 — Pfizer-BioNTech
- 2021-06-22
-
2021-06-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-06-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-06-26
- 2021-06-27
- 2021-06-28
- 2021-06-29
- 2021-07-06
- 2021-07-13
- 2021-07-20
- 2021-07-27
- 2021-08-03
-
2021-09-21
Survey response — 3 months, dose 2MedDRA: Anaemia, Gestational diabetes — Feeling: GoodFree text: Gestational diabetes and anemiaMedDRA releases: 2024-11 · check-in free text available
- 2021-12-21
-
2021-12-28
Dose 3 — Moderna
-
2021-12-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-12-30
-
2021-12-31
Survey response — days 1–6 daily, dose 3MedDRA: Breast feeding — Feeling: Good · Site: PainFree text: Breastfed baby has been very lethargicMedDRA releases: 2024-11 · check-in free text available
- 2022-01-01
- 2022-01-03
- 2022-01-04
- 2022-01-11
- 2022-01-18
- 2022-01-25
- 2022-02-01
- 2022-02-08
- 2022-03-29
-
2022-06-28
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: GoodFree text: Covid positiveMedDRA releases: 2024-11 · check-in free text available
- 2022-12-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-01 | Pfizer-BioNTech | |
| 2 | 2021-06-22 | Pfizer-BioNTech | No |
| 3 | 2021-12-28 | Moderna | No |
Free text
Release 9 — 3 months, dose 2
Symptoms: Gestational diabetes and anemia
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Breastfed baby has been very lethargic
Release 12 — 6 months, dose 3
Symptoms: Covid positive
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anaemia | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Gestational diabetes | · | · | ✓ |
| SRO | Breast feeding | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release